During the past decade, Glenny Corp SA conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Glenny Corp SA" are "Atherosclerotic Cardiovascular Disease" (1 trials) and "Coronary Heart Disease (CHD)" (1 trials). Many other conditions were trialed in "Glenny Corp SA" in a lesser frequency.

Most popular intervention types in "Glenny Corp SA" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Evolocumab" (1 trials), "Lp(a) Screening" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Glenny Corp SA" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Glenny Corp SA". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Glenny Corp SA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Glenny Corp SA, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".